- Home
- CAPT vs MIRA Comparison
CAPT vs MIRA Comparison
Compare CAPT & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- MIRA
- Stock Information
- Founded
- CAPT 2005
- MIRA 2020
- Country
- CAPT South Korea
- MIRA United States
- Employees
- CAPT N/A
- MIRA N/A
- Industry
- CAPT Blank Checks
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- MIRA Health Care
- Exchange
- CAPT Nasdaq
- MIRA Nasdaq
- Market Cap
- CAPT 31.2M
- MIRA 25.2M
- IPO Year
- CAPT N/A
- MIRA 2023
- Fundamental
- Price
- CAPT $0.83
- MIRA $1.52
- Analyst Decision
- CAPT
- MIRA
- Analyst Count
- CAPT 0
- MIRA 0
- Target Price
- CAPT N/A
- MIRA N/A
- AVG Volume (30 Days)
- CAPT 154.6K
- MIRA 8.5M
- Earning Date
- CAPT 01-01-0001
- MIRA 11-11-2025
- Dividend Yield
- CAPT N/A
- MIRA N/A
- EPS Growth
- CAPT N/A
- MIRA N/A
- EPS
- CAPT N/A
- MIRA N/A
- Revenue
- CAPT $17,389,944.00
- MIRA N/A
- Revenue This Year
- CAPT N/A
- MIRA N/A
- Revenue Next Year
- CAPT N/A
- MIRA N/A
- P/E Ratio
- CAPT N/A
- MIRA N/A
- Revenue Growth
- CAPT 84.70
- MIRA N/A
- 52 Week Low
- CAPT $0.37
- MIRA $0.73
- 52 Week High
- CAPT $1.94
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- CAPT 39.02
- MIRA 56.68
- Support Level
- CAPT $0.82
- MIRA $1.35
- Resistance Level
- CAPT $0.86
- MIRA $2.45
- Average True Range (ATR)
- CAPT 0.05
- MIRA 0.15
- MACD
- CAPT 0.00
- MIRA 0.03
- Stochastic Oscillator
- CAPT 10.25
- MIRA 23.33
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.